NEUK203-215 Injection

· Neukio Biotherapeutics (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEUK203-215 Injection, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]

See pricing